Viewing Study NCT03641794


Ignite Creation Date: 2025-12-25 @ 1:46 AM
Ignite Modification Date: 2026-02-28 @ 3:47 AM
Study NCT ID: NCT03641794
Status: UNKNOWN
Last Update Posted: 2019-08-01
First Post: 2018-08-15
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Indoleamine 2,3-Dioxygenase (IDO) Inhibitor in Healthy Volunteers
Sponsor: Jiangxi Qingfeng Pharmaceutical Co. Ltd.
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: DN-DN1406131-101
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None INDUSTRY View